Page last updated: 2024-08-26

bosentan anhydrous and meclofenamic acid

bosentan anhydrous has been researched along with meclofenamic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cases, A; Gomez-Alamillo, C; Haas, JA; Juncos, LA; Romero, JC1

Reviews

1 review(s) available for bosentan anhydrous and meclofenamic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for bosentan anhydrous and meclofenamic acid

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bosentan; Cyclooxygenase Inhibitors; Dogs; Endothelin Receptor Antagonists; Enzyme Inhibitors; Female; Hemodynamics; Iliac Artery; Kidney; Lung; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Receptor, Angiotensin, Type 1; Regional Blood Flow; Sodium; Sulfonamides; Vasoconstriction; Vasodilation

2003